Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial

Oza, Amit, Cook, Adrian D, Pfisterer, Jacobus, Embleton, Andrew, Ledermann, Jonathan A., Pujade-lauraine, Eric, Kristensen, Gunnar, Carey, Mark S, Beale, Philip, Cervantes, Andrés, Park-Simon, Tjoung-Won, Rustin, Gordon Js, Joly, F, Mirza, Mansoor R., Plante, Marie, Quinn, Michael, Poveda, Andres, Jayson, Gordon C, Stark, Dan, Swart, Ann Marie, Farrelly, Laura, Kaplan, Richard S, Parmar, Mahesh K.b. and Perren, Timothy J. (2015) Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial. The Lancet Oncology, 16 (8). 928–936. ISSN 1470-2045

[img]
Preview
PDF (ICON7 OS results Lancet 2015) - Published Version
Available under License Creative Commons Attribution.

Download (415kB) | Preview
Item Type: Article
Uncontrolled Keywords: sdg 3 - good health and well-being ,/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
Depositing User: Pure Connector
Date Deposited: 24 Jul 2015 23:03
Last Modified: 27 Oct 2021 01:16
URI: https://ueaeprints.uea.ac.uk/id/eprint/53798
DOI: 10.1016/S1470-2045(15)00086-8

Actions (login required)

View Item View Item